GL検索 v0.1.0
画像は 90 ページを描画したものです
page 90

p.90 抽出テキスト

weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med 2009; 122: 535-542. PMID: 19486716 319. Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg 2014; 24: 437-455. PMID: 24374842 320. Eckert DJ, Elgar NJ, McEvoy RD, et al. Alcohol alters sensory processing to respiratory stimuli in healthy men and women during wakefulness. Sleep 2 0 1 0 ; 3 3 : 1 3 8 9 - 1 3 9 5 . PMID: 21061862 321. Mitler MM, Dawson A, Henriksen SJ, et al. Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res 1988; 12: 801-805. PMID: 3064641 322. Simou E, Britton J, Leonardi-Bee J. Alcohol and the risk of sleep apnoea: a systematic review and meta-analysis. Sleep Med 2018; 42: 38-46. PMID: 29458744 323. Wetter DW, Young TB, Bidwell TR, et al. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994; 154: 2219- 2224. PMID: 7944843 324. Krishnan V, Dixon-Williams S, Thornton JD. Where there is smoke...there is sleep apnea: Exploring the relationship between smoking and sleep apnea. Chest 2014; 146: 1673- 1680. PMID: 25451354 325. Dolly FR, Block AJ. Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med 1982; 73: 239-243. PMID: 7051825 326. Wang D, Marshall NS, Duffin J, et al. Phenotyping interindividual variability in obstructive sleep apnoea response to temazepam using ventilatory chemoreflexes during wakefulness. J Sleep Res 2011; 20: 526-532. PMID: 21668806 327. Eckert DJ, Owens RL, Kehlmann GB, et al. Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. Clin Sci (Lond) 2011; 120: 505-514. PMID: 21269278 328. Carberry JC, Grunstein RR, Eckert DJ. The effects of zolpidem in obstructive sleep apnea – An open-label pilot study. J Sleep Res 2019; 28: e12853. PMID: 30968498 329. Sun H, Palcza J, Card D, et al. Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea. J Clin Sleep Med 2016; 12: 9- 17. PMID: 26194728 330. Cheng JY, Filippov G, Moline M, et al. Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double-blind, placebo-controlled, crossover study. J Sleep Res 2020; 29: e 13021. PMID: 32187781 331. Kline CE, Crowley EP, Ewing GB, et al. The effect of exercise training on obstructive sleep apnea and sleep quality: a randomized controlled trial. Sleep 2011; 34: 1631- 1640. PMID: 22131599 332. Awad KM, Malhotra A, Barnet JH, et al. Exercise is associated with a reduced incidence of sleep-disordered breathing. Am J Med 2012; 125: 485-490. PMID: 22482846 333. Mendelson M, Inami T, Lyons O, et al. Long-term effects of cardiac rehabilitation on sleep apnea severity in patients with coronary artery disease. J Clin Sleep Med 2020; 16: 65-71. PMID: 31957654 334. Yingjuan M, Siang WH, Leong Alvin TK, et al. Positional Therapy for Positional Obstructive Sleep Apnea. Sleep Med Clin 2020; 15: 261-275. PMID: 32386700 335. Cartwright RD. Effect of sleep position on sleep apnea severity. Sleep 1984; 7: 110-114. PMID: 6740055 336. Joosten SA, O’Driscoll DM, Berger PJ, et al. Supine position related obstructive sleep apnea in adults: pathogenesis and treatment. Sleep Med Rev 2014; 18: 7-17. PMID: 23669094 337. Levendowski DJ, Seagraves S, Popovic D, et al. Assessment of a neck-based treatment and monitoring device for positional obstructive sleep apnea. J Clin Sleep Med 2014; 10: 863- 871. PMID: 25126032 338. van Maanen JP, Meester KA, Dun LN, et al. The sleep position trainer: a new treatment for positional obstructive sleep apnoea. Sleep Breath 2013; 17: 771-779. PMID: 22927107 339. Bignold JJ, Mercer JD, Antic NA, et al. Accurate position monitoring and improved supine-dependent obstructive sleep apnea with a new position recording and supine avoidance device. J Clin Sleep Med 2011; 7: 376-383. PMID: 21897774 340. Laub RR, Tønnesen P, Jennum PJ. A Sleep Position Trainer for positional sleep apnea: a randomized, controlled trial. J Sleep Res 2017; 26: 641-650. PMID: 28370716 341. Eijsvogel MM, Ubbink R, Dekker J, et al. Sleep position trainer versus tennis ball technique in positional obstructive sleep apnea syndrome. J Clin Sleep Med 2015; 11: 139-147. PMID: 25515276 342. Barnes H, Edwards BA, Joosten SA, et al. Positional modification techniques for supine obstructive sleep apnea: A systematic review and meta-analysis. Sleep Med Rev 2017; 36: 107- 115. PMID: 28012784 343. Ha SC, Hirai HW, Tsoi KK. Comparison of positional therapy versus continuous positive airway pressure in patients with positional obstructive sleep apnea: A meta-analysis of randomized trials. Sleep Med Rev 2014; 18: 19-24. PMID: 23831268 344. Srijithesh PR, Aghoram R, Goel A, et al. Positional therapy for obstructive sleep apnoea. Cochrane Database Syst Rev 2019: CD010990. PMID: 31041813 345. Wellman A, Eckert DJ, Jordan AS, et al. A method for measuring and modeling the physiological traits causing obstructive sleep apnea. J Appl Physiol ( 1985) 2011; 110: 1627- 1637. PMID: 21436459 346. Wellman A, Edwards BA, Sands SA, et al. A simplified method for determining phenotypic traits in patients with obstructive sleep apnea. J Appl Physiol ( 1985) 2013; 114: 911- 922. PMID: 23349453 347. Taranto-Montemurro L, Messineo L, Wellman A. Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature. J Clin Med 2019; 8: 1846. PMID: 31684047 348. Yee BJ, Phillips CL, Banerjee D, et al. The effect of sibutramineassisted weight loss in men with obstructive sleep apnoea. Int J Obes (Lond) 2007; 31: 161-168. PMID: 16652122 349. Ferland A, Poirier P, Sériès F. Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients. Eur Respir J 2009; 34: 694-701. PMID: 19357147 350. Blackman A, Foster GD, Zammit G, et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond) 2016; 40: 1310-1319. PMID: 27005405 351. Winslow DH, Bowden CH, DiDonato KP, et al. A randomized, double-blind, placebo-controlled study of an oral, extendedrelease formulation of phentermine/topiramate for the treatment of obstructive sleep apnea in obese adults. Sleep 2012; 35: 1529- 1539. PMID: 23115402 352. Gaddam K, Pimenta E, Thomas SJ, et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 2010; 24: 532-537. PMID: 20016520 353. Kasai T, Bradley TD, Friedman O, et al. Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension. J Hypertens 2014; 32: 673-680. PMID: 24284499 354. Fiori CZ, Martinez D, Montanari CC, et al. Diuretic or sodiumrestricted diet for obstructive sleep apnea a randomized trial. Sleep 2018; 41: zsy016. PMID: 29669139 355. Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax 2004; 59: 50-55. PMID: 14694248 356. Koutsourelakis I, Minaritzoglou A, Zakynthinos G, et al. The effect of nasal tramazoline with dexamethasone in obstructive sleep apnoea patients. Eur Respir J 2013; 42: 1055-1063. PMID: 23397296 357. Kraiczi H, Hedner J, Dahlöf P, et al. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 1999; 22: 61-67. PMID: 9989366 358. Hedner J, Kraiczi H, Peker Y, et al. Reduction of sleep-disordered breathing after physostigmine. Am J Respir Crit Care Med 2003; 168: 1246-1251. PMID: 12958052 359. Chan E, Steenland HW, Liu H, et al. Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states. Am J Respir Crit Care Med 2006; 174: 1264- 1273. PMID: 16931636 360. Berry RB, Yamaura EM, Gill K, et al. Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea. Sleep 1999; 22: 1087-1092. PMID: 10617169 361. Marshall NS, Yee BJ, Desai AV, et al. Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. Sleep 2008; 31: 824-831. PMID: 18548827 362. Taranto-Montemurro L, Messineo L, Sands SA, et al. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double- Blind Crossover Trial. Am J Respir Crit Care Med 2019; 199: